NASDAQ: BMRBeamr Imaging Ltd Stock
$5.50-0.16 (-2.83%)
Updated Apr 25, 2024
BMR Price
$5.50
Fair Value Price
$0.33
Market Cap
$71.78M
52 Week Low
$0.91
52 Week High
$34.94
P/E
-91.67x
P/B
7x
P/S
5.58x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.91M
Earnings
-$695.00k
Gross Margin
96.7%
Operating Margin
-30.18%
Profit Margin
-23.9%
Debt to Equity
0.12
Operating Cash Flow
-$659k
Beta
-0.03
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BMR Overview
Beamr Imaging Ltd. provides video encoding, transcoding, and optimization solutions in the United States, Israel, and internationally. The company offers a suite of video compression software encoder solutions, including Beamr 4, Beamr 4X content adaptive, Beamr 5, and Beamr 5X content adaptive encoders; Beamr JPEGmini photo optimization software solutions for reducing joint photographic experts group file sizes; and Beamr Silicon IP block, a hardware solution for integration into dedicated video encoding application-specific integrated circuits, graphics processing units, and application processors. It serves tier one over-the-top platforms, content distributors, video streaming platforms, and Hollywood studios. The company was formerly known as I.C.V.T Ltd. and changed its name to Beamr Imaging Ltd. in January 2015. The company was incorporated in 2009 and is headquartered in Herzliya, Israel.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BMR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BMR ($5.50) is overvalued by 1,576.8% relative to our estimate of its Fair Value price of $0.33 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
BMR ($5.50) is not significantly undervalued (1,576.8%) relative to our estimate of its Fair Value price of $0.33 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BMR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BMR due diligence checks available for Premium users.
Be the first to know about important BMR news, forecast changes, insider trades & much more!
BMR News
Valuation
BMR fair value
Fair Value of BMR stock based on Discounted Cash Flow (DCF)
Price
$5.50
Fair Value
$0.33
Overvalued by
1,576.80%
BMR ($5.50) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BMR ($5.50) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BMR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
BMR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-91.67x
Industry
101.91x
Market
40.97x
BMR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
7x
Industry
6.49x
BMR is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BMR's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
BMR's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
BMR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$11.5M
Liabilities
$1.3M
Debt to equity
0.12
BMR's short-term assets ($6.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BMR's short-term assets ($6.85M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BMR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
BMR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BMR vs App Stocks
Beamr Imaging Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.